Skip to content
Fall Sale 40% off everything Ends in Offer ends November 30.

VIP Research Guide: Identity, Literature, Analysis and Documentation

Research use only. StarBio products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This guide covers identity, documentation and handling only. It is not usage guidance.

VIP is a 28-residue peptide of the secretin and glucagon family, found in nerves of the gut, the brain and many other tissues. As a research reagent it has been in use for half a century. As a material it is a moderately large, basic peptide with a methionine and three asparagines, each of which leaves a recognisable trace when a lot has been stored badly. This page collects the identity data, the research areas the literature covers, the analytical points, and the report on file for StarBio’s lot.

Identity

Name VIP (vasoactive intestinal peptide)
Type Synthetic 28-residue neuropeptide, C-terminally amidated
CAS number 37221-79-7
Molecular weight 3326.8 g/mol
Formula C147H237N43O43S
Sequence His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
Length 28 amino acids

Origin and history

VIP was isolated in 1970 by Sami Said and Viktor Mutt from pig small intestine, and named for the first thing it was seen to do in their preparations: relax blood vessels. Within a few years it was found in neurons throughout the body and reclassified as a neuropeptide. It acts through two receptors, VPAC1 and VPAC2, which it shares with the related peptide PACAP. Its literature is correspondingly broad.

What the literature covers

The references on file for this compound span several research areas. They are listed here as areas of study, not as results.

  • Immune signalling. A 1990 paper on VIP in a neuroimmune axis [3] and a 2013 review of its immune functions [6].
  • The gut. A 2020 Nature paper on a feeding-dependent circuit and the intestinal barrier [7], and studies of the VPAC1 receptor along the intestine and in gut microbiota homeostasis [9, 11].
  • Circulation and kidney. Adipose tissue blood flow (2025) [4] and renin secretion (1988) [5].
  • Receptor pharmacology. Simplified analogues with receptor selectivity (2005) [8], receptor antagonists (2026) [10] and heparin oligosaccharide binding (2024) [2].
  • Cell migration. A 2022 study of VIP and VPAC2 signalling in tumour cells [1].

This is the literature of a natural signalling molecule across many tissues, listed as areas of study.

Analytical notes

Three kinds of change mark a degraded lot of VIP. The methionine at position 17 oxidises to the sulfoxide, adding 16 Da and eluting slightly earlier. The asparagines at positions 9, 24 and 28 can deamidate, each adding 1 Da, with the one before serine at position 24 the most susceptible. And loss of the C-terminal amide also adds 1 Da. Identity is confirmed by deconvolution to the 3326.8 average mass.

With two tyrosines the peptide absorbs at 280 nm as well as at 220 nm. It is strongly basic, with five lysine and arginine residues, and adsorbs readily to glass and untreated plastic at low concentration, so low-binding labware matters for quantitative work. The report on file for this compound is an identity and content report and does not carry an HPLC purity figure, which the table below shows as it is.

Storage and stability

  • Lyophilized powder
  • Store at -20 °C
  • Protect from light
  • Avoid repeated freeze-thaw cycles
  • In solution: 2-8 °C, short term

Documentation for StarBio lots

Every StarBio lot is analysed by an independent laboratory. The table lists the report on file for this compound.

Variant Laboratory / report HPLC purity Labelled / measured Tested
VIP 10 mg Janoshik Analytical #136378 identity / content 10 mg report

Current certificates are in the COA Library; the verify-lot form connects an order to its batch record.

References

  1. Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration. Frontiers in oncology, 2022, PMID 36237322.
  2. Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization. Current protein & peptide science, 2024, PMID 38284716.
  3. Vasoactive intestinal peptide. Messenger in a neuroimmune axis. Annals of the New York Academy of Sciences, 1990, PMID 2165755.
  4. Vasoactive Intestinal Peptide: Another Player in Adipose Tissue Blood Flow Regulation?. Microcirculation (New York, N.Y. : 1994), 2025, PMID 40946317.
  5. Vasoactive intestinal peptide and renin secretion. Annals of the New York Academy of Sciences, 1988, PMID 3291698.
  6. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino acids, 2013, PMID 22139413.
  7. Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier. Nature, 2020, PMID 32050257.
  8. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors. The Journal of pharmacology and experimental therapeutics, 2005, PMID 15994369.
  9. The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota. Gastro hep advances, 2022, PMID 36910129.
  10. Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activity. The Journal of biological chemistry, 2026, PMID 41478571.
  11. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. American journal of physiology. Gastrointestinal and liver physiology, 2017, PMID 28385693.

Product page: VIP. Related guides: Thymosin Alpha-1 research guide, KPV research guide, what 99% purity means, storing lyophilized peptides.

For laboratory research use only. Not for human or veterinary use.

Questions about VIP

What is VIP?

VIP is a 28-residue neuropeptide, C-terminally amidated: 28 residues, molecular weight 3326.8 g/mol, CAS number 37221-79-7. It is supplied for in vitro laboratory research only. This guide covers identity, documentation and handling, not use.

Is VIP the same as Vasoactive intestinal peptide?

VIP is also listed as Vasoactive intestinal peptide. On a certificate or vial label, the CAS number (37221-79-7) and the sequence identify the material regardless of which name is used.

What are the CAS number, formula and molecular weight of VIP?

VIP has CAS number 37221-79-7, molecular formula C147H237N43O43S and molecular weight 3326.8 g/mol. Sequence: His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2. Identity of each StarBio batch is confirmed by mass spectrometry on the laboratory report.

Is StarBio's VIP independently tested?

Yes. The current VIP batch was tested by Janoshik Analytical (Janoshik Analytical report #136378). The report is on file in the COA library (report page). Janoshik Analytical reports can be checked on janoshik.com with the report number.

How should VIP be stored?

Lyophilized powder; Store at -20 °C; Protect from light; Avoid repeated freeze-thaw cycles; In solution: 2-8 °C, short term. StarBio ships it as sealed lyophilized powder.

Where can I buy VIP for laboratory research?

StarBio sells VIP as 10 mg at $49.99, shipped tracked from Florida to all 50 US states. StarBio does not ship internationally. Buyers must be qualified researchers or institutions aged 21 or older, buying for in vitro laboratory work.

New reports and guides, by email

A short note when a new laboratory report is published, when a compound returns to stock, and when a new guide goes up. Nothing else. Leave whenever you like.

For laboratory research use only. No dosing or protocol content is ever sent.

StarBio

Researcher verification

StarBio supplies research compounds only to qualified researchers and laboratories, for in vitro laboratory use. Enter your date of birth and confirm your research use to continue.

You must be 21 or older.

By continuing you affirm that the date and statement above are true. Products are supplied for laboratory research only: not for human or veterinary use, not for diagnostic procedures, and not evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Not a researcher? Exit